If you, or a loved one, have been diagnosed with Memory loss or mild cognitive impairment or Mild Alzheimer’s disease, taking medications such as Aricept, Exelon, Namenda, Razadyne, you may be eligible for a Research Study, evaluating the safety and effectiveness of investigational drugs for Memory loss due to Alzheimer’s disease.
Qualified participants must be at least 50 years of age, taking a stable dose of medication for Alzheimer’s such as Aricept, Exelon, Namenda, have a caregiver to accompany them to study visits, and meet additional study criteria.
Participants will receive all study-related care and study medication at no cost. Health insurance is not needed to participate.
To find out more about our Research Studies, and to see if you qualify, call 609-895-0735.